Correlation between Vitamin D Levels and Antimicrobial Peptide LL-37 in Pediatric Patients Diagnosed with Sepsis

Abstract

Objective Our objective was to examine potential differences in inflammatory markers, specifically antimicrobial peptide (AMP) LL-37 and interleukin-6 (IL-6), in the bloodstream of children with sepsis who had varying levels of vitamin D3.

Methods A total of 59 pediatric patients diagnosed with sepsis from January 2021 to November 2021 were enrolled in this study. The pediatric patients with sepsis were categorized into three groups based on their levels of vitamin D3, and AMP LL-37, IL-6, and procalcitonin (PCT) were compared among the three groups.

Discussion The LL-37 level in the group with vitamin D3 deficiency was notably lower than in the other two groups (p _{deficiency group vs. insufficiency group} = 0.019, p _{deficiency group vs. normal group} = 0.034), whereas the disparity between the group with vitamin D3 insufficiency and the group with normal vitamin D3 levels was not statistically significant. There was a positive correlation between the level of vitamin D3 and LL-37 in pediatric patients with sepsis (r = 0.324, p = 0.012). On the other hand, the level of IL-6 in pediatric patients with sepsis showed a positive correlation with both LL-37 (r = 0.474, p = 0.000) and PCT (r = 0.527, p = 0.000).

Conclusion Pediatric patients with sepsis typically exhibit low levels of vitamin D3, which are positively correlated with the levels of serum LL-37. Furthermore, the presence of higher levels of serum LL-37 is positively correlated with higher levels of IL-6.

Keywords

antimicrobial peptide - LL-37 - IL-6 - sepsis - vitamin D₃

Publikationsverlauf

Eingereicht: 21. November 2023

Angenommen: 03. April 2024

Artikel online veröffentlicht:
11. Mai 2024

• References

• 1 Weiss S-L, Fitzgerald J-C, Pappachan J. et al; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191 (10) 1147-1157
• 2 Liu P-T, Stenger S, Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311 (5768): 1770-1773
• 3 Gombart A-F, Borregaard N, Koeffler H-P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005; 19 (09) 1067-1077
• 4 Takeuti FAC, Guimaraes FSF, Guimaraes PSF. Applications of vitamin D in sepsis prevention. Discov Med 2018; 25 (140) 291-297
• 5 Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122 (02) 398-417
• 6 Holick M-F, Binkley N-C, Bischoff-Ferrari H-A. et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (07) 1911-1930
• 7 Yu W, Ying Q, Zhu W, Huang L, Hou Q. Vitamin D status was associated with sepsis in critically ill children: a PRISMA compliant systematic review and meta-analysis. Medicine (Baltimore) 2021; 100 (02) e23827
• 8 Su G, Jia D. Vitamin D in Acute and Critically Sick Children with a Subgroup of Sepsis and Mortality: A Meta-Analysis. Nutr Cancer 2021; 73 (07) 1118-1125
• 9 Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M, Amado JA, Cacho PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol 2012; 91 (05) 829-838
• 10 Adams J-S, Ren S, Liu P-T. et al. Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182 (07) 4289-4295
• 11 Huang L, Ji YJ, Xu X, Guo N. The correlation analysis between 25-hydroxy vitamin D3 and LL-37 in neonatal sepsis. Ningxia Medical Journal 2018; 40 (04) 334-335
• 12 Ji YJ. Levels and Effects of 25-Hydroxyvitamin D and Antimicrobial Peptide LL-37 in Neonatal Sepsis. Ningxia Medical University; 2018
• 13 Svensson D, Nebel D, Nilsson B-O. Vitamin D3 modulates the innate immune response through regulation of the hCAP-18/LL-37 gene expression and cytokine production. Inflamm Res 2016; 65 (01) 25-32
• 14 Zavala-Jonguitud L-F, Anda J-C, Flores-Padilla M-G, Pérez C, Juárez-Villa JD. [Correlation between insufficiency or deficiency of vitamin D levels and interleukins 1β and 6]. Rev Alerg Méx 2021; 68 (03) 180-184
• 15 Abdel-Hady H, Yahia S, Megahed A. et al. Mediators in preterm infants with late-onset sepsis: a randomized controlled trial. J Pediatr Gastroenterol Nutr 2019; 68 (04) 578-584
• 16 Wang Y, Yang Z, Gao L, Cao Z, Wang Q. Effects of a single dose of vitamin D in septic children: a randomized, double-blinded, controlled trial. J Int Med Res 2020; 48 (06) 300060520926890
• 17 Aydemir G, Cekmez F, Kalkan G. et al. High serum 25-hydroxyvitamin D levels are associated with pediatric sepsis. Tohoku J Exp Med 2014; 234 (04) 295-298
• 18 Deng YC, Tang XC, Huang CZ, Mo LY. Study of 25-hydroxy vitamin D level and correlation in children with severe pneumonia. Int J Lab Med 2017; 38 (02) 221-223
• 19 Deng Y-C, Tang X-C, Yuan Y-H, Huang CZ, Mo LY. [Dynamic change in vitamin D level in infants/toddlers with severe pneumonia and a correlation analysis]. Zhongguo Dang Dai Er Ke Za Zhi 2018; 20 (11) 911-916
• 20 Bian F, Wu Y-E, Zhang C-L. Variation in the levels of IL-6 in pediatric patients with severe bacterial infectious diseases and correlation analysis between the levels of IL-6 and procalcitonin. Exp Ther Med 2017; 13 (06) 3484-3488
• 21 Jiang Y, Liao H, Zhang X. et al. IL-33 synergistically promotes the proliferation of lung cancer cells in vitro by inducing antibacterial peptide LL-37 and proinflammatory cytokines in macrophages. Immunobiology 2020; 225 (06) 152025
• 22 Pistolic J, Cosseau C, Li Y. et al. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. J Innate Immun 2009; 1 (03) 254-267
• 23 Filewod N-C, Pistolic J, Hancock R-E. Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli. FEMS Immunol Med Microbiol 2009; 56 (03) 233-240
• 24 Dahl S, Cerps S, Rippe C. et al. Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells. Inflamm Res 2020; 69 (06) 579-588
• 25 Félix-Gastélum R, Herrera-Rodríguez G, Martínez-Valenzuela C. et al. First report of powdery mildew (Podosphaera pannosa) of roses in Sinaloa, Mexico. Plant Dis 2014; 98 (10) 1442
• 26 Kusaka S, Nishida A, Takahashi K. et al. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease. Clin Exp Immunol 2018; 191 (01) 96-106
• 27 Chen X, Takai T, Xie Y, Niyonsaba F, Okumura K, Ogawa H. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Biochem Biophys Res Commun 2013; 433 (04) 532-537